Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adele K Fielding

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
Blood|October 27, 2019
Response: Chemotherapy or allografting for young adults with high-risk ALL?Anthony H Goldstone, Susan M Richards, Adele K Fielding, et al.
Journal of Virology|April 23, 2002
Strength of envelope protein interaction modulates cytopathicity of measles virusRichard K Plemper, Anthea L Hammond, Denis Gerlier, et al.
The Journal of Gene Medicine|November 20, 2002
Lack of specificity of cell-surface protease targeting of a cytotoxic hyperfusogenic gibbon ape leukaemia virus envelope glycoproteinLucy A Kirkham, Andrew R Bateman, Alan A Melcher, et al.
Blood|December 19, 2013
Human mesenchymal stromal cells deliver systemic oncolytic measles virus to treat acute lymphoblastic leukemia in the presence of humoral immunityAnna Castleton, Aditi Dey, Brendan Beaton, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 18, 2015
The Role of Neutrophils in Measles Virus-mediated Oncolysis Differs Between B-cell Malignancies and Is Not Always Enhanced by GCSFAditi Dey, Yu Zhang, Anna Z Castleton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2011
Attenuated, oncolytic, but not wild-type measles virus infection has pleiotropic effects on human neutrophil functionYu Zhang, Bella Patel, Aditi Dey, et al.
Leukemia & Lymphoma|October 4, 2019
Inotuzumab ozogamicin versus FLAG-Ida in the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia - real-world resource use dataCatherine S Y Lecat, Caroline Besley, Rachael E Hough, et al.
British Journal of Haematology|November 10, 2009
Antigen receptor gene rearrangements reflect on the heterogeneity of adult Acute Lymphoblastic Leukaemia (ALL) with implications of cell-origin of ALL subgroups - a UKALLXII studyLena Rai, Anouska Casanova, Anthony V Moorman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 8, 2003
An oncolytic measles virus engineered to enter cells through the CD20 antigenAmanda D Bucheit, Shaji Kumar, Deanna M Grote, et al.
British Journal of Haematology|May 10, 2022
Antibody responses to SARS-CoV-2 vaccination in patients with acute myeloid leukaemia and high risk MDS on active anti-cancer therapiesWei Yee Chan, Catherine Zhu, Emilie Sanchez, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Blood|October 27, 2019
Response: Chemotherapy or allografting for young adults with high-risk ALL?Anthony H Goldstone, Susan M Richards, Adele K Fielding, et al.
Journal of Virology|April 23, 2002
Strength of envelope protein interaction modulates cytopathicity of measles virusRichard K Plemper, Anthea L Hammond, Denis Gerlier, et al.
The Journal of Gene Medicine|November 20, 2002
Lack of specificity of cell-surface protease targeting of a cytotoxic hyperfusogenic gibbon ape leukaemia virus envelope glycoproteinLucy A Kirkham, Andrew R Bateman, Alan A Melcher, et al.
Blood|December 19, 2013
Human mesenchymal stromal cells deliver systemic oncolytic measles virus to treat acute lymphoblastic leukemia in the presence of humoral immunityAnna Castleton, Aditi Dey, Brendan Beaton, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 18, 2015
The Role of Neutrophils in Measles Virus-mediated Oncolysis Differs Between B-cell Malignancies and Is Not Always Enhanced by GCSFAditi Dey, Yu Zhang, Anna Z Castleton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2011
Attenuated, oncolytic, but not wild-type measles virus infection has pleiotropic effects on human neutrophil functionYu Zhang, Bella Patel, Aditi Dey, et al.
Leukemia & Lymphoma|October 4, 2019
Inotuzumab ozogamicin versus FLAG-Ida in the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia - real-world resource use dataCatherine S Y Lecat, Caroline Besley, Rachael E Hough, et al.
British Journal of Haematology|November 10, 2009
Antigen receptor gene rearrangements reflect on the heterogeneity of adult Acute Lymphoblastic Leukaemia (ALL) with implications of cell-origin of ALL subgroups - a UKALLXII studyLena Rai, Anouska Casanova, Anthony V Moorman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 8, 2003
An oncolytic measles virus engineered to enter cells through the CD20 antigenAmanda D Bucheit, Shaji Kumar, Deanna M Grote, et al.
British Journal of Haematology|May 10, 2022
Antibody responses to SARS-CoV-2 vaccination in patients with acute myeloid leukaemia and high risk MDS on active anti-cancer therapiesWei Yee Chan, Catherine Zhu, Emilie Sanchez, et al.
Pageof 9